Gilead Sciences (GILD)
$66.69
0.10 (0.15%)
GILD Stock Quote Delayed 30 Minutes
AFLAC Incorporated Is Even More Attractive After Earnings (AFL)
With the release of Q1 earnings and future guidance, insurer AFLAC Incorporated shows why it is a long term hold for savvy investors' portfolios
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
83.62B
PE Ratio
190.54
EPS
0.35
Volume (Avg. Vol.)
4.21M
Day's Range
$66.01 - $66.93
52-Week Range
$62.07 - $87.86
Dividend & Yield
$3.00 (4.50%)
GILD Stock Predictions, Articles, and Gilead Sciences News
Why Gilead Sciences, Inc. (GILD), Stericycle Inc (SRCL) and Western Digital Corp (WDC) Are 3 of Today’s Worst Stocks
Gilead Sciences (GILD), Stericycle (SRCL) and Western Digital (WDC) were all doomed from the beginning of Friday's trading.
Biggest Movers in Manufacturing Stocks Now – TLGT CYBE BGS MNST
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD) and TiVo, Inc. (TIVO)
Amgen (AMGN) and Gilead Sciences (GILD) will be moving Friday on earnings news, while TiVo (TIVO) will get a modest buyout bump.
Gilead Sciences, Inc. (GILD): Decent Earnings, But Going NOWHERE
Gilead Sciences (GILD) stock will remain undervalued regardless of strong Q1 earnings -- until it puts all that money to work.
5 Stocks That Could Hike Their Dividends 20%
With valuations stretched, earnings sagging, and a forecast drop for S&P companies, it's nice to find these 5 dividend stock opportunities to profit
5 Dividend Stocks Starting a Multi-Decade Bull Market
A 'niche" bull run is in the market that's going to continue for the long term. Healthcare stocks are solid long-term portfolio dividend stocks to buy
Gilead Sciences, Inc. (GILD) Buys Nimbus Therapeutics Subsidiary for $1.2B
Gilead Sciences has announced that it will be acquiring Nimbus Therapeutics' Nimbus Apollo, Inc. subsidiary for up to $1.2 billion.
Why Freeport-McMoRan Inc (FCX), Gilead Sciences, Inc. (GILD) and Tesla Motors Inc (TSLA) Are 3 of Today’s Worst Stocks
Gilead Sciences, Inc. (GILD), Freeport-McMoRan (FCX) and Tesla Motors (TSLA) never even had a prayer of gains on Wednesday.
Gilead Sciences, Inc.: GILD Could Squeeze the Bears From Here
Gilead Sciences enjoyed a rally Monday along with the rest of the biotech sector. This breakout could be followed up by a short squeeze in GILD stock.
The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is a Buy, But Not for Long
The iShares Nasdaq Biotechnology ETF (IBB) has yet to pull off something that other parts of the market have -- and that spells opportunity in IBB.
Gilead Sciences, Inc.: Short the Looming Value Trap in GILD Stock
GILD stock is looking ripe for the picking in biotech market that appears to be seeing a bounce, but Gilead is a value trap waiting to snap.
2 Drug Stocks To Buy For Safe Dividends And 20% Gains
With all the talk on the campaign trail about drug costs, it's safe to say the pharmaceutical industry is under siege. But these drug stocks are solid buys
62 Stock Upgrades (and Downgrades) for the Week
During these time it pays to stay on top of the latest profit opportunities. Today's blog post is be a great place to start with these 62 trades to make
Thursday’s Vital Data: Bank of America Corp (BAC), Gilead Sciences, Inc. (GILD) and Kinder Morgan Inc (KMI)
Bank of America (BAC) call options soar on strong consumer credit, Gilead’s (GILD) Harvoni gets a new FDA indication and Kinder Morgan (KMI) is bolstered by Buffett.
Trade of the Day: Oversold GILD Stock Offers Good Risk/Reward Setup
Traders have the chance to play a sharp bounce in Gilead Sciences, Inc.
